Clinical studies in melanoma and ovarian cancer have demonstrated that MHC class I overexpression is associated with the activation of the programmed death-ligand 1 (PD-L1)/programmed death-1 (PD-1) axis, leading to the functional impairment of cytotoxic T lymphocytes (CTLs) [6,20]. This evidence concerns the gene CD274 and melanoma.